Dr. Ashraf Dallol, PhD in Biomedical Science from the University of Ulster and Chief Scientific Director at NoorDx, provided an in-depth look at the use of Next-Generation Sequencing (NGS) technology in advancing genomics research and clinical applications. He underscored the instrumental role of MGI sequencers in powering NoorDx's research initiatives.

Dr. Dallol is optimistic about a future where NGS technology is further applied to deliver cost-effective, accurate and reliable clinical reports, ultimately benefiting more patients.